FABP3 and Parkinson disease: Interestingly, when mice lacking the FABP3 gene were subjected to treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to induce PD-like symptoms, cells sampled from midbrain lacked the characteristic accumulation of αSyn that could typically be observed in WT mice.